DEA Places Synthetic Drug in Schedule I
The Drug Enforcement Administration permanently placed 2-methyl AP-237, a synthetic drug that acts like an opioid, in Schedule I of the Controlled Substances Act, in a final rule released March 14. New registration, labeling, record-keeping, and import and export requirements…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
under the final rule take effect April 15.